RedC Biotech
Universal Red Blood Cells for Life Saving Transfusions and Advanced Therapies
Company Overview
Snapshot
Founded in April 2015 by Ari Gargir, RedC Biotech operates with 1–10 employees. The company has secured $3M in total capital across 4 funding rounds from 1 investor. In March 2022, RedC Biotech received a grant, highlighting its ongoing development in the biotechnology sector.
Business overview
RedC Biotech is a pre-clinical development stage company focused on creating universal red blood cells from stem cells. Utilizing a patented cultivation technology, the company aims to develop a highly scalable process to meet global demand for safe red blood cell transfusions. Its technology provides a universal blood type suitable for almost any patient, with potency comparable to existing transfusions. RedC Biotech serves the healthcare and life sciences sectors, including providers, laboratories, and pharmaceutical companies, through a B2B business model.
Strategic signal
In June 2022, RedC Biotech was highlighted for its work in producing donor-less blood in the lab to alleviate shortages, signaling a significant advancement in addressing critical global healthcare needs. This development indicates the company's potential to revolutionize blood transfusion practices and reduce reliance on traditional blood donation systems, positioning it as a key innovator in the biotechnology space.
Log in to access full profile ›Company Intelligence Q&A
- What is RedC Biotech's primary focus?
- RedC Biotech is dedicated to developing universal red blood cells from stem cells using a patented cultivation technology, aiming to provide a safe and scalable solution for blood transfusions worldwide.
- When was RedC Biotech founded?
- RedC Biotech was founded in April 2015.
- Who is the founder of RedC Biotech?
- Ari Gargir is the founder of RedC Biotech.
- What was a notable recognition for RedC Biotech in March 2022?
- In March 2022, Ari Gargir from RedC Biotech won the Ziv Aviram Fund competition in Dubai.
- What was a key development for RedC Biotech in June 2022?
- In June 2022, RedC Biotech was recognized for producing donor-less blood in a lab to address blood shortages, showcasing its innovative approach to blood supply.